Research study Program year 2021 Source: CMS Open Payments

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ensovibep (Mp0420) in Ambulatory Adult Patients With Symptomatic Covid-19 (The Empathy Trial)

Research payments

$3,976,595

40 payments

Through program year 2021, $3,976,595 in research payments was reported against A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ensovibep (Mp0420) in Ambulatory Adult Patients With Symptomatic Covid-19 (The Empathy Trial), across 40 payments, paid by Novartis Pharmaceuticals Corporation.

Paid by: Novartis Pharmaceuticals Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$3,976,595	40

Breakdown

Who paid Research payments · program year 2021

Novartis Pharmaceuticals Corporation $3,976,595 40 payments

Who received the money Research payments · program year 2021

Epic Medical Research Organisation paid for research $630,711 1 payment
Clinnova Organisation paid for research $437,177 4 payments
Future Innovative Treatments Organisation paid for research $427,418 2 payments
Monroe Biomedical Research Organisation paid for research $409,606 1 payment
Iact Health Organisation paid for research $305,712 1 payment
Suncoast Research Group Organisation paid for research $178,726 1 payment
Biopharma Informatic LLC Organisation paid for research $172,132 5 payments
Benchmark Research Attn Ben Lacy Cfo Organisation paid for research $171,353 1 payment
Life Spring Research Foundation Organisation paid for research $169,713 1 payment
Ascada Health Pc Organisation paid for research $168,360 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.